All Stories

  1. The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

    Article • Breast Cancer Targets and Therapy, July 2017, Dove Medical Press

    Prof. Marc-Eric Halatsch

  2. Session 38: Organ and patient support systems II

    Article • Biomedical Engineering / Biomedizinische Technik, January 2017, De Gruyter

    Prof. Marc-Eric Halatsch

  3. A cocktail of repurposed drugs for targeted therapy of glioblastoma

    Article • OncoTargets and Therapy, April 2016, Dove Medical Press

    Prof. Marc-Eric Halatsch, Masume maleki behzad, Professor Najmaldin Saki

  4. Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib

    Article • Journal of Neurosurgery, August 2009, Journal of Neurosurgery Publishing Group (JNSPG)

    Prof. Marc-Eric Halatsch

  5. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines

    Article • Journal of Neurosurgery, March 2004, Journal of Neurosurgery Publishing Group (JNSPG)

    Prof. Marc-Eric Halatsch

  6. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines

    Article • Neurosurgical FOCUS, February 2004, Journal of Neurosurgery Publishing Group (JNSPG)

    Prof. Marc-Eric Halatsch

  7. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor messenger RNA

    Article • Journal of Neurosurgery, February 2000, Journal of Neurosurgery Publishing Group (JNSPG)

    Prof. Marc-Eric Halatsch